FSPM — Fusion Pharm Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Fusion Pharm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	1996 September 30th	1997 September 30th	1997 December 31st	2011 December 31st	2012 December 31st
Period Length:	12 M	12 M	3 M	12 M	12 M
Source:	10-K	10-K	10KSB	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7.99	0.883	0.03	0.227	0.808
Cost of Revenue
Gross Profit	-1.1	-2.09	-0.204	0.069	0.676
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	10.7	3.17	0.334	0.619	0.516
Operating Profit	-2.66	-2.29	-0.304	-0.392	0.292
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2.26	-0.871	-0.406	-0.402	0.265
Provision for Income Taxes
Net Income After Taxes	-2.28	-0.883	-0.406	-0.402	0.265
Net Income Before Extraordinary Items
Net Income	-2.28	-0.883	-0.406	-0.402	0.265
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-2.28	-0.883	-0.406	-0.402	0.265
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-17.4	-6.83	-4.24	-0.159	0.106
Dividends per Share